Blood Vessels, Thrombosis & Hemostasis

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Blood Vessels, Thrombosis & Hemostasis is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,000 USD. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2950-3272
Country
United States
Languages
english
Access
Open access
Declared publication charge
3,000 USD
Articles in DOAJ
77
Declared review time
14 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2024-11-18
Indexing
DOAJ
APC
3,000 USD
Declared review time (DOAJ)
14 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

77

Most recent article

last month

Average review time (journal-declared via DOAJ)

14weeks

Works in OpenAlex

182

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

7

i10-index

5

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2026-04-27
Added to DOAJ
2024-11-18
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
88%
ORCID iDs in current deposits
96%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918957761606676
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs

LCC codes

RC633-647.5

Subject areas

  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Venous Thromboembolism Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Hemophilia Treatment and Research
  • Hemophilia Treatment and Research
  • Blood Coagulation and Thrombosis Mechanisms
Show all subjects (50)
  • Complement system in diseases
  • Complement system in diseases
  • Blood groups and transfusion
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Hemoglobinopathies and Related Disorders
  • Blood groups and transfusion
  • Hemoglobinopathies and Related Disorders
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Cell Adhesion Molecules Research
  • Cell Adhesion Molecules Research
  • Blood properties and coagulation
  • Blood properties and coagulation
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Atrial Fibrillation Management and Outcomes
  • Blood transfusion and management
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Atrial Fibrillation Management and Outcomes
  • Blood transfusion and management
  • Chronic Myeloid Leukemia Treatments
  • Iron Metabolism and Disorders
  • Chronic Myeloid Leukemia Treatments
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Vascular Malformations and Hemangiomas
  • Iron Metabolism and Disorders
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Inflammatory Biomarkers in Disease Prognosis
  • Blood disorders and treatments
  • Vascular Malformations and Hemangiomas
  • Acute Ischemic Stroke Management
  • Acute Ischemic Stroke Management
  • Blood disorders and treatments
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Angiogenesis and VEGF in Cancer

Keywords (DOAJ)

  • hematology
  • thrombosis
  • hemostasis
  • bleeding disorders
  • vascular medicine
  • vascular biology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: